Gene therapy restores hearing in children wit

<p>A novel gene therapy for hearing loss was administered to six children in China in a clinical trial co-led by investigators at Mass Eye and Ear in Boston and Eye &amp; ENT Hospital of Fudan University in Shanghai, China. Each child had an inherited deafness caused by mutations in the&nbsp;<em>OTOF </em>gene<em>,</em> called DFNB9. The researchers report in a new study in&nbsp;<em>The Lancet</em>, after 26 weeks, five children demonstrated hearing recovery and dramatic improvements in speech perception and the restored ability to conduct normal conversation.&nbsp;With its first patient treated in December 2022, this research represents the first human clinical trial to administer gene therapy for treating this form of hearing loss, with the most patients treated and longest follow-up conducted to date.</p>

Related Keywords

Shanghai ,China ,Massachusetts ,United States ,Mengzhao Xun ,Jiajia Zhang ,Kaiyu Gao ,Huawei Li ,Longlong Zhang ,Renjie Chai ,Jinghan Wang ,Luoying Jiang ,Sha Yu ,Zheng Yi Chen ,Xiaoting Cheng ,Yilai Shu ,Wuqing Wang ,Luo Guo ,Qi Cao ,Zijing Wang ,Biyun Zhu ,Honghai Tang ,Bing Chen ,Shui Wang ,Daqi Wang ,Ziwen Gao ,Chong Cui ,Yuxin Chen ,Hospital Of Fudan University At ,National Key Rd Program Of China ,Method Of Research ,Technology Commission Of Shanghai Municipality ,National Natural Science Foundation Of China ,Shanghai Refreshgene Therapeutics Co Ltd ,Instagram ,Facebook ,Twitter ,Harvard Medical School ,Neck Surgery At Harvard Medical School ,Association For Research ,Hospital Of Fudan University ,Mass Eye ,Mass General Brigham ,Fudan University ,Eaton Peabody Laboratories ,Neck Surgery ,Harvard Medical ,Otolaryngology Annual ,Yanbo Yin ,National Natural Science Foundation ,National Key Rd Program ,Technology Commission ,Shanghai Municipality ,Shanghai Refreshgene ,Autosomal Recessive Deafness ,Hospitals Survey ,World Report ,